Cuu Long Pharmaceutical JSC (HOSE:DCL)
55,000
+600 (1.10%)
At close: Mar 9, 2026
HOSE:DCL Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 19,516 | 53,571 | 61,717 | 111,641 | 85,961 | Upgrade
|
| Depreciation & Amortization | 53,416 | 37,856 | 38,278 | 38,135 | 34,273 | Upgrade
|
| Other Amortization | - | 401.69 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -6,106 | - | -8,884 | -25,617 | -43,737 | Upgrade
|
| Other Operating Activities | 9,901 | -5,065 | 5,872 | 7,005 | -4,989 | Upgrade
|
| Change in Accounts Receivable | 42,440 | 8,662 | -14,709 | -384,124 | -105,671 | Upgrade
|
| Change in Inventory | -21,294 | 16,311 | -55,033 | -9,758 | -83,805 | Upgrade
|
| Change in Accounts Payable | -43,488 | -27,074 | -1,479 | -161,826 | 214,295 | Upgrade
|
| Change in Other Net Operating Assets | -6,596 | -4,850 | -3,233 | -1,001 | 3,380 | Upgrade
|
| Operating Cash Flow | 47,791 | 69,813 | 22,530 | -450,071 | 29,437 | Upgrade
|
| Operating Cash Flow Growth | -31.55% | 209.86% | - | - | -68.47% | Upgrade
|
| Capital Expenditures | -88,040 | -172,850 | -222,874 | -233,028 | -152,612 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 370.64 | 250.12 | - | Upgrade
|
| Investment in Securities | - | - | 44,346 | 292,923 | - | Upgrade
|
| Other Investing Activities | 5,026 | 6,467 | 9,151 | 33,032 | 56,947 | Upgrade
|
| Investing Cash Flow | -101,013 | -166,382 | -169,006 | 93,177 | 224,393 | Upgrade
|
| Long-Term Debt Issued | 1,204,636 | 1,199,477 | 973,672 | 1,218,898 | 2,427,584 | Upgrade
|
| Long-Term Debt Repaid | -1,181,044 | -1,075,364 | -856,533 | -1,205,603 | -2,702,031 | Upgrade
|
| Net Debt Issued (Repaid) | 23,592 | 124,113 | 117,138 | 13,295 | -274,447 | Upgrade
|
| Issuance of Common Stock | - | - | - | 355,205 | 20,000 | Upgrade
|
| Financing Cash Flow | 23,592 | 124,113 | 117,138 | 368,500 | -254,447 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.05 | 8.1 | 2.59 | -8.99 | -5.76 | Upgrade
|
| Net Cash Flow | -29,631 | 27,552 | -29,335 | 11,596 | -622.67 | Upgrade
|
| Free Cash Flow | -40,249 | -103,037 | -200,343 | -683,099 | -123,174 | Upgrade
|
| Free Cash Flow Margin | -3.05% | -7.89% | -17.51% | -67.25% | -17.51% | Upgrade
|
| Free Cash Flow Per Share | -550.64 | -1410.67 | -2742.89 | -9736.25 | -2142.18 | Upgrade
|
| Cash Interest Paid | - | 25,437 | 29,199 | 35,991 | 33,237 | Upgrade
|
| Cash Income Tax Paid | - | 14,964 | 12,576 | 25,261 | 33,440 | Upgrade
|
| Levered Free Cash Flow | 90,686 | -134,124 | -187,565 | -814,492 | -31,418 | Upgrade
|
| Unlevered Free Cash Flow | 121,392 | -118,190 | -168,484 | -789,725 | -8,753 | Upgrade
|
| Change in Working Capital | -28,938 | -16,951 | -74,453 | -581,234 | -42,071 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.